Table 4.

Change in secondary laboratory endpoints from baseline to 30 days follow-up

Parameters	Placebo (n = 59)		t	P	Tongxinluo capsules (n = 60)		t	P
	Baseline	30 days			Baseline	30 days
Plasma fibrinogen (g/L)	4.2 ± 0.9	4.2 ± 0.9	−0.081	0.935	4.3 ± 0.8	4.4 ± 0.8	-0.898	0.371
Thrombin time (s)	13.3 ± 1.6	13.5 ± 1.1	−0.797	0.427	13.3 ± 1.3	13.7 ± 1.1	-1.514	0.133
Prothrombin time (s)	13.1 ± 0.8	13.3 ± 1.0	−1.163	0.247	13.0 ± 1.1	13.2 ± 1.0	-0.828	0.409
hsCRP (mg/L)	2.0 ± 1.0	1.8 ± 0.8	0.932	0.353	2.0 ± 1.2	1.4 ± 0.7	1.999	0.048

Data are presented as mean ± standard deviation. hsCRP: High-sensitivity C-reactive protein.